Continuous positive airway pressure (CPAP) interface devices units provide breathing assistance to patients suffering from obstructive sleep apnea/hypopnea syndrome (SAHS) or sleep apnea (OSA). Continuous positive airway pressure (CPAP) interface devices units are also utilized as a preventive and support device for patients suffering from other diseases, such as acute asthma, cardiogenic pulmonary edema, congestive heart failure and chronic lung disease (CLD) cystic fibrosis. Continuous positive airway pressure (CPAP) interface devices consist of a flow generator or ‘blower’, a length of tubing, and a tight-fitting face mask, nasal mask, or nasal nares. The continuous positive airway pressure (CPAP) interface devices market was valued at US$ 2,616.3 Mn in 2018 and is projected to reach US$ 4,171.6 Mn by 2027, expanding at a CAGR of 5.4% from 2019 to 2027.

Rise in the number of COPD patients, increase in prevalence of sleep apnea, surge in government expenditure on health care in emerging markets, strategic alliance between key and small players in emerging markets such as India, and increase in geriatric population are major factors that are anticipated to drive the global continuous positive airway pressure (CPAP) interface devices market. Furthermore, high cost of respiratory devices and lack of patient compliance are key factors that are projected to restrain the market.

In terms of interface devices, the global continuous positive airway pressure (CPAP) interface devices market has been segmented into face mask, nasal mask, oral mask, and helmets. The nasal mask segment dominated the continuous positive airway pressure (CPAP) interface devices market in 2018, due to a rise in the prevalence of respiratory diseases. Based on age group, the continuous positive airway pressure (CPAP) interface devices market has been bifurcated into neonates & infants and adults. Increase in the prevalence of respiratory disorders is anticipated to drive the continuous positive airway pressure (CPAP) interface devices market. Based on end-user, the continuous positive airway pressure (CPAP) interface devices market is bifurcated into hospitals & clinics, home healthcare, sleep laboratories, and others.

continuous positive airway pressure cpap interface devices market1

In terms of region, the global continuous positive airway pressure (CPAP) interface devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the global continuous positive airway pressure (CPAP) interface devices market in 2018. The continuous positive airway pressure (CPAP) interface devices market in North America is driven by the presence of key players and high rate of adoption of technologies in the region. Additionally, a rise in the prevalence of respiratory disease is likely to propel the continuous positive airway pressure (CPAP) interface devices market in the region. Increase in the geriatric population in the U.S. and a rise in the incidence of respiratory and COPD diseases, and a surge in the prevalence of sleep apnea are projected to boost the continuous positive airway pressure (CPAP) interface devices market during the forecast period. The continuous positive airway pressure (CPAP) interface devices market in Europe is driven by an increase in the prevalence of respiratory disorders.

continuous positive airway pressure cpap interface devices market

The global continuous positive airway pressure (CPAP) interface devices market is highly fragmented, due to the presence of a large number of players. Major players operating in the global continuous positive airway pressure (CPAP) interface devices market include Philips Healthcare (Koninklijke Philips N.V.), Fisher & Paykel Healthcare Limited, ResMed Inc., Mercury Medical (Mercury Enterprises, Inc.), Pulmodyne, Inc., O-Two Medical Technologies Inc., Dimar s.r.l., Intersurgical Ltd., HAROL S.r.l., and Vygon SA.

Increase in trend of mergers & acquisitions and product approvals & launches in developing countries is expected to boost the global continuous positive airway pressure (CPAP) interface devices market during the forecast period. Additionally, acquisition provides growth in core part of business.

Global Continuous Positive Airway Pressure (CPAP) Interface Devices Market: Overview

  • The global continuous positive airway pressure (CPAP) interface devices market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on interface devices, age group, end-user, and region.
  • A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises a competitive matrix and company profiles along with business overview to understand the competitive landscape in the market.
  • This section of the report also provides market attractiveness analysis, by region, thereby presenting a thorough analysis of the overall competitive scenario in the global continuous positive airway pressure (CPAP) interface devices market.

Global Continuous Positive Airway Pressure (CPAP) Interface Devices Market: Key Segments

  • In terms of interface devices, the global continuous positive airway pressure (CPAP) interface devices market has been segmented into face mask, nasal mask, oral mask, and helmets. Based on age group, the market has been classified into adults and neonates & infants. Based on end-user, the market has been classified into hospitals & clinics, home healthcare, sleep laboratories, and others.
  • The home healthcare segment is anticipated to expand at a significant CAGR during the forecast period. The market has been analyzed based on price variations, technology trends, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. 

Global Continuous Positive Airway Pressure (CPAP) Interface Devices Market: Regional Outlook

  • In terms of region, the global continuous positive airway pressure (CPAP) interface devices market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries, and Rest of Middle East & Africa).
  • The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions. 

Companies Mentioned in Report

  • The report also profiles major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Some of the key companies profiled in the global continuous positive airway pressure (CPAP) interface devices market include
  • Philips Healthcare (Koninklijke Philips N.V.)
  • Fisher & Paykel Healthcare Limited, ResMed Inc.
  • Mercury Medical (Mercury Enterprises, Inc.)
  • Pulmodyne, Inc.
  • O-Two Medical Technologies Inc.
  • Dimar s.r.l.
  • Intersurgical Ltd.
  • HAROL S.r.l.
  • Vygon SA.

The global continuous positive airway pressure (CPAP) interface devices market has been segmented as follows:

Interface Devices

  • Face Mask
  • Nasal Mask
  • Oral Mask
  • Helmets

Age Group

  • Neonates & Infants
  • Adults

End-user

  • Hospitals & Clinics
  • Home Healthcare
  • Sleep Laboratories
  • Others

Region

  • North America
    • U.S.
    • Canada 
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe 
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific 
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America 
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa